Skip navigation

Chemical Rosiglitazone

Name Rosiglitazone
CAS Type 1 Name 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-
Equivalent Terms 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate | Avandia | BRL49653 | BRL 49653 | BRL-49653 | Rosiglitazone Maleate
Definition A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.
Top Interacting
Genes
MeSH® ID D000077154
External Links
DrugBank
DB00412
PubChem
D000077154
TOXLINE®
Query

Top ↑ Ancestors

1. Chemicals ← Organic Chemicals Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Sulfur Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Thiazoles Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Thiazolidinediones Has associated genes Has associated diseases Has associated phenotype references ← Rosiglitazone Has associated genes Has associated diseases Has associated phenotype references
2. Chemicals ← Heterocyclic Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Heterocyclic Compounds, 1-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Azoles Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Thiazoles Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references ← Thiazolidinediones Has associated genes Has associated diseases Has associated phenotype references ← Rosiglitazone Has associated genes Has associated diseases Has associated phenotype references

Top ↑ Descendants

None.